Ownership of Corporate Names. As between the Parties, each Party shall retain all right, title and interest in and to its Corporate Names.

Ownership of Corporate Names. As between the Parties, Licensor shall retain all right, title and interest in and to its Corporate Names.

Ownership of Corporate Names. As between the Parties, [[AstraZeneca:Organization]] shall retain all rights, title and interests in and to [[AstraZeneca:Organization]] Corporate Names and Licensee shall retain all rights, title and interests in and to Licensee Corporate Names.

Corporate and Fictitious Names; Trade Names. No Borrower has, during the preceding five (5) years, # been known as or used any other corporate, fictitious or trade names, # been the surviving corporation of a merger or consolidation, or # acquired all or substantially all of the assets of any Person.

Ownership of Corporate Names. As between the Parties, each Party shall retain all right, title and interest in and to its Corporate Names.

Ownership of Corporate Names. As between the Parties, NPLH and/or Spero Parent shall retain all right, title and interest in and to its Corporate Names.

Ownership of Corporate Names. As between the Parties, [[AstraZeneca:Organization]] shall retain all right, title and interest in and to its Corporate Names.

Use of Corporate Names. The Lead Party shall use Commercially Reasonable Efforts to include the Participating Party’s name with ​ on materials related to the Product (including package inserts, packaging, trade packaging, internet pages, social media, samples and all Promotional Materials used or distributed in connection with the Product), unless to do so CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “​”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE [[Unknown Identifier]] PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

Ownership of Corporate Names. As between the Parties, # REGENX shall retain all right, title and interest in and to its Corporate Names and # PARTNER shall retain all right, title and interest in and to its Corporate Names.

Corporate Names. The Parties shall not, and shall not permit their Affiliates or its or their sublicensees to, # use in their respective businesses, any Trademark that is confusingly similar to, misleading or deceptive with respect to or that dilutes any (or any part) of the [[AstraZeneca:Organization]] Corporate Names, in the case of Licensee, or the Licensee Corporate Names, in the case of [[AstraZeneca:Organization]]; # do any act that endangers, destroys or similarly affects, in any material respect, the value of the goodwill pertaining to the [[AstraZeneca:Organization]] Corporate Names, in the case of Licensee, or the Licensee Corporate Names, in the case of [[AstraZeneca:Organization]]; or # contest the validity of or ownership of the [[AstraZeneca:Organization]] Corporate Names, in the case of Licensee, or the Licensee Corporate Names, in the case of [[AstraZeneca:Organization]], anywhere in the Territory or any registrations issued or issuing with respect thereto or any pending registration thereof. Licensee agrees, and shall cause its Affiliates and Sublicensees, to conform # to the customary industry standards for the protection of the [[AstraZeneca:Organization]] Corporate Names and to such trademark usage guidelines as [[AstraZeneca:Organization]] may furnish from time to time with respect to the use of the [[AstraZeneca:Organization]] Corporate Names and # to adhere to and maintain the quality standards of [[AstraZeneca:Organization]] with respect to goods sold and services provided under the [[AstraZeneca:Organization]] Corporate Names.